EHBP1

Across TCGA pan-cancer cohorts, EHBP1 mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated EHBP1 data layer compared with 25 for mass-spec protein and 6 for mutation status.

The strongest signal is observed in uterine corpus endometrial carcinoma (UCEC), where higher EHBP1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated EHBP1 expression acts as an unfavorable survival marker.

UCEC, LSCC, and LUAD are the cancer types where EHBP1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCEC	OS	Median	III,IV	0.311	1.000	.001	28	view →
LSCC	OS	Median	III,IV	0.400	0.882	.003	17	view →
LUAD	OS	Quartile	II,III,IV	0.331	0.766	.021	10	view →
GBM	DFS	Quartile	All	0.291	0.554	.003	8	view →
PDAC	OS	Median	II,III,IV	0.392	0.584	.015	5	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

EHBP1–UCEC (OS)

Open the UCEC breakdown →